APT: Phage therapy co BiomX merges with APT, raises $50m
The Israeli company's share price jumped 150% on the news.
Read full article »
Interim-CEO
Ian Hardy
APT is a Maryland-based biotechnology company that researches and develops antimicrobial therapeutics to treat multidrug-resistant infections.
Read more